Fulvestrant With or Without Lapatinib and/or Aromatase Inhibitor Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer That Progressed After Previous Aromatase Inhibitor Therapy
Clinical trial NCT00688194 · UNKNOWN
Trial details
- NCT number
- NCT00688194
- Sponsor
- Gruppo Italiano Mammella (GIM)
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2013-05-01
- Enrollment
- 396
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.